Journals / Anadolu Kardiyoloji Dergisi / 2003 / Cilt: 3 - Sayı: 1

Koroner arter hastalığı, vasküler sendrom X ve sağlıklı olgularda plazma homosistein, koroner risk faktörleri ve serum nitrit ilişkisi

The association of plasma homocysteine, cardiac risk factors and serum nitrite in patients with coronary artery disease, cardiac syndrome X and healthy subjects

Pages
26–34
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Coronary artery disease patients had higher median plasma tHcy levels than cardiac syndrome X patients (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We evaluated the association of plasma total homocysteine (tHcy), cardiac risk factors and total nitrite in coronary artery disease (CAD) patients, cardiac syndrome X patients and in healthy subjects.
📊
Key Findings & Data:Methods: Forty two CAD, 22 cardiac syndrome X patients and 30 healthy subjects, aged 30 to 75 years were included into the study.
💡
Conclusion & Impact:Coronary artery disease patients had higher median plasma tHcy levels than cardiac syndrome X patients (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We evaluated the association of plasma total homocysteine (tHcy), cardiac risk factors and total nitrite in coronary artery disease (CAD) patients, cardiac syndrome X patients and in healthy subjects. Methods: Forty two CAD, 22 cardiac syndrome X patients and 30 healthy subjects, aged 30 to 75 years were included into the study. Blood samples of tHcy, serum total nitrite and cardiac risk factors were studied appropriately. The results were compared between the groups. The independent contributions of tHcy and total nitrite to CAD and cardiac syndrome X and their interactions with cardiac risk factors were evaluated. Results: After adjusting for age, median values of tHcy and total nitrite were evaluated for their skewness. Coronary artery disease patients had higher median plasma tHcy levels than cardiac syndrome X patients (p

Özet

Amaç: Bu çalışmada koroner arter hastalığı (KAH)'nda, kardiyak sendrom X'de ve sağlıklu bireylerde plazma total homosistein (tHcy),kardiyak risk faktörleri ve serum total nitrit ilişkisi araştırıldı. Yöntem:Otuz-yetmiş beş yaş arasında 42 KAH, 22 kardiyak sendrom X ve 30 sağlıklı birey çalışmaya alındı.Tüm olgularda usulüne uygun biçimde plazma tHcy, serum total nitrit ve kardiyak risk faktörleri çalışıldı.Sonuçlar gruplar arasında karşılaştırıldı. Total Hcy ,total nitrit ve kardiyak risk faktörlerinin kendi aralarındaki, KAH ve kardiyak sendrom X ile olan bağıntıları incelendi.Bulgular:Yaşa göre düzeltme yapılarak uygulanan istatistik değerlendirmede, sağa çarpık dağılım gösteren plazma tHcy'in mediyan değeri koroner arter hastalarında kardiyak sendrom X ve kontrol grubuna göre yüksek (p

🔖

Cite This Article

SAVAŞ, S., SUSAM, İ., SÖZMEN, E., ÇEVİK, Ç., GÖLDELİ, E., SOYSAL, D., GÜNERİ, S. (2022). Koroner arter hastalığı, vasküler sendrom X ve sağlıklı olgularda plazma homosistein, koroner risk faktörleri ve serum nitrit ilişkisi. Anadolu Kardiyoloji Dergisi, Cilt: 3 - Sayı: 1, 26–34. https://ajindex.com/articles/437542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Fallon UB, Ben-Shlomo Y, Elwood P, Ubbink JB, Smith D. Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up. Heart 2001; 85: 153-8
  2. Foody J.Homocysteine: Discovering a new predictor of coronary disease. Clinican Reviews 1998; 8: 203-10
  3. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. New Eng J Med 1998; 338: 1042-9
  4. Prasad K. Homocysteine, a risk factor for cardiovascular disease. Int J Angiol 1999; 8: 76-86
  5. Stamler JS, Osborne JA, Joraki O, et al. Adverse vascular effects of homocysteine are modulated by endothelium derived relaxing factor and related oxides of nitrogens. J Clin Invest 1993; 91: 308-18
  6. Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607
  7. Bozkurt E, Emek A, Erol MK et al. Sigara içenlerde ve içmeyenlerde nitrik oksit seviyeleri. Türk Kardiyol Dern Arş 2001; 29: 31-5
  8. Jousilahti P, Vartiainen E, Korhonen HJ, Puska P, Tuomilehto. Is the effect of smoking on the risk for coronary heart disease even stronger than was previously thought ? J Cardiovasc Risk 1999; 6: 293-8
  9. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Eng J Med 1997; 337: 230-6
  10. Bardsley WT, Mankin HT, Miller TD. Electrocardiography. Exercise Testing. In Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV, editors. Mayo Clinic Practise of Cardiology. Saint Louise: Mosby-Year Book, Inc; 1996. p. 114-41
  11. Radice M, Giudici V, Albertini A, Mannarini A. Usefulness of changes in exercise tolerance induced by nitroglycerine in identifying patients with syndrome X. Am Heart J 1994; 127: 531-5
  12. Lanza GA, Manzoli A, Bia E, Crea F, Maseri A. Acute effects of nitrates on exercise testing in patients with syndrome X. Circulation 1994; 90: 2695-700
  13. Ponikowski P, Rosano GMC, Amadi AA, et al. Coronary artery disease/autonomic dysfunction precedes ST segment depression inpatients with syndrome X. Am J Cardiol 1996; 77: 942-7
  14. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination homocystein in plasma and serum. Eur J Clin Chem Clin Biochem 1991; 29: 549-54
  15. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrite and nitrate in biological fluids. Anal Biochem 1982; 126: 131-8
  16. Sucu M, Karadede AA, Toprak N, Homosistein ve kardiyovasküler hastalıkları